List of Tables
Table 1. Global Neuromodulation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Internal Treatment
Table 3. Key Players of External Treatment
Table 4. Global Neuromodulation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Neuromodulation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Neuromodulation Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Neuromodulation Market Share by Region (2018-2023)
Table 8. Global Neuromodulation Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Neuromodulation Market Share by Region (2024-2029)
Table 10. Neuromodulation Market Trends
Table 11. Neuromodulation Market Drivers
Table 12. Neuromodulation Market Challenges
Table 13. Neuromodulation Market Restraints
Table 14. Global Neuromodulation Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Neuromodulation Market Share by Players (2018-2023)
Table 16. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation as of 2022)
Table 17. Ranking of Global Top Neuromodulation Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Neuromodulation Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neuromodulation Product Solution and Service
Table 21. Date of Enter into Neuromodulation Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuromodulation Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Neuromodulation Revenue Market Share by Type (2018-2023)
Table 25. Global Neuromodulation Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Neuromodulation Revenue Market Share by Type (2024-2029)
Table 27. Global Neuromodulation Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Neuromodulation Revenue Market Share by Application (2018-2023)
Table 29. Global Neuromodulation Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Neuromodulation Revenue Market Share by Application (2024-2029)
Table 31. North America Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Neuromodulation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Neuromodulation Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Neuromodulation Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Neuromodulation Product
Table 49. Medtronic Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Boston Scientific Corporation Company Detail
Table 52. Boston Scientific Corporation Business Overview
Table 53. Boston Scientific Corporation Neuromodulation Product
Table 54. Boston Scientific Corporation Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 55. Boston Scientific Corporation Recent Development
Table 56. Abbott Company Detail
Table 57. Abbott Business Overview
Table 58. Abbott Neuromodulation Product
Table 59. Abbott Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. LivaNova Company Detail
Table 62. LivaNova Business Overview
Table 63. LivaNova Neuromodulation Product
Table 64. LivaNova Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 65. LivaNova Recent Development
Table 66. Synapse Biomedical, Inc. Company Detail
Table 67. Synapse Biomedical, Inc. Business Overview
Table 68. Synapse Biomedical, Inc. Neuromodulation Product
Table 69. Synapse Biomedical, Inc. Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 70. Synapse Biomedical, Inc. Recent Development
Table 71. Nevro Corporation Company Detail
Table 72. Nevro Corporation Business Overview
Table 73. Nevro Corporation Neuromodulation Product
Table 74. Nevro Corporation Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 75. Nevro Corporation Recent Development
Table 76. NeuroSigma Company Detail
Table 77. NeuroSigma Business Overview
Table 78. NeuroSigma Neuromodulation Product
Table 79. NeuroSigma Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 80. NeuroSigma Recent Development
Table 81. NeuroPace Company Detail
Table 82. NeuroPace Business Overview
Table 83. NeuroPace Neuromodulation Product
Table 84. NeuroPace Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 85. NeuroPace Recent Development
Table 86. Neuronetics Company Detail
Table 87. Neuronetics Business Overview
Table 88. Neuronetics Neuromodulation Product
Table 89. Neuronetics Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 90. Neuronetics Recent Development
Table 91. BioControl Medical Company Detail
Table 92. BioControl Medical Business Overview
Table 93. BioControl Medical Neuromodulation Product
Table 94. BioControl Medical Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 95. BioControl Medical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromodulation Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Neuromodulation Market Share by Type: 2022 VS 2029
Figure 3. Internal Treatment Features
Figure 4. External Treatment Features
Figure 5. Global Neuromodulation Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Neuromodulation Market Share by Application: 2022 VS 2029
Figure 7. Ischemia Case Studies
Figure 8. Chronic Pain Case Studies
Figure 9. Parkinson’s Case Studies
Figure 10. Depression Case Studies
Figure 11. Tremor Case Studies
Figure 12. Epilepsy Case Studies
Figure 13. Migraine Case Studies
Figure 14. Neuromodulation Report Years Considered
Figure 15. Global Neuromodulation Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Neuromodulation Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Neuromodulation Market Share by Region: 2022 VS 2029
Figure 18. Global Neuromodulation Market Share by Players in 2022
Figure 19. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Neuromodulation Revenue in 2022
Figure 21. North America Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Neuromodulation Market Share by Country (2018-2029)
Figure 23. United States Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Neuromodulation Market Share by Country (2018-2029)
Figure 27. Germany Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Neuromodulation Market Share by Region (2018-2029)
Figure 35. China Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Neuromodulation Market Share by Country (2018-2029)
Figure 43. Mexico Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Neuromodulation Market Share by Country (2018-2029)
Figure 47. Turkey Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Medtronic Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 50. Boston Scientific Corporation Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 51. Abbott Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 52. LivaNova Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 53. Synapse Biomedical, Inc. Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 54. Nevro Corporation Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 55. NeuroSigma Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 56. NeuroPace Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 57. Neuronetics Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 58. BioControl Medical Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed